Cannell & Spears’s Humana HUM Stock Holding History

Cannell & Spears’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-822	Closed	-$260K	–	408
2024 Q3	$260K	Sell	822 -1,080	-57%	-$384K	0.01%	351
2024 Q2	$711K	Buy	1,902 +742	+64%	+$251K	0.01%	244
2024 Q1	$402K	Buy	+1,160	New	+$440K	0.01%	297

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cannell & Spears's HUM Position: Q4 2024 in Review

Cannell & Spears sold out of Humana (HUM) in Q4 2024, closing a stake of 822 shares — an estimated $260K sold.

Cannell & Spears first reported a position in HUM in Q1 2024 and held it in 3 quarters. The position peaked at $711K in Q2 2024. 879 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

Cannell & Spears reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
Cannell & Spears sold 822 Humana shares in Q4 2024, an estimated $260K.
Cannell & Spears first reported a position in Humana in Q1 2024 and held it in 3 quarters.
Cannell & Spears's Humana position peaked at $711K in Q2 2024.
879 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Cannell & Spears's 13F filing for Q4 2024, filed 12 Feb 2025.